We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+0.64%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.26B
AUM Growth
-$618M
(-11%)
Cap. Flow
-$615M
Cap. Flow
% of AUM
-11.69%
Top 10 Holdings %
Top 10 Hldgs %
13.58%
Holding
928
New
151
Increased
197
Reduced
368
Closed
132
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$43.8M |
| 2 |
UnitedHealth
UNH
|
+$42.1M |
| 3 |
Verizon
VZ
|
+$32.3M |
| 4 |
Comcast
CMCSA
|
+$29.1M |
| 5 |
Citigroup
C
|
+$23.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$70.8M |
| 2 |
Apple
AAPL
|
+$38.4M |
| 3 |
Johnson & Johnson
JNJ
|
+$36.3M |
| 4 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$31.3M |
| 5 |
International Flavors & Fragrances
IFF
|
+$28.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.72% |
| 2 | Healthcare | 17.4% |
| 3 | Technology | 16.88% |
| 4 | Industrials | 10.63% |
| 5 | Consumer Discretionary | 10.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Kelly Services Class A
KELYA
$526M
| $276K | 0.01% |
+18,000
| New | +$295K |
|
|
ECHO
677
DELISTED
Echo Global Logistics, Inc.
ECHO
| $276K | 0.01% |
8,450
| – | – |
|
|
GUID
678
DELISTED
Guidance Software, Inc.
GUID
| $275K | 0.01% |
32,435
-32,348
| -50% | -$220K |
|
|
CUTR
679
DELISTED
Cutera, Inc.
CUTR
| $272K | 0.01% |
+17,600
| New | +$252K |
|
|
ANAD
680
DELISTED
ANADIGICS INC
ANAD
| $271K | 0.01% |
370,895
+307,495
| +485% | +$317K |
|
681
Patterson-UTI
PTEN
$3.87B
| $268K | 0.01% |
+14,240
| New | +$295K |
|
|
NSPH
682
DELISTED
NANOSPHERE INC. COM NEW
NSPH
| $267K | 0.01% |
82,382
+68,240
| +483% | +$262K |
|
683
Dawson Geophysical
DWSN
$155M
| $265K | 0.01% |
+59,184
| New | +$303K |
|
684
Visteon
VC
$2.77B
| $264K | 0.01% |
+2,517
| New | +$265K |
|
|
RNDY
685
DELISTED
ROUNDYS INC COM STK
RNDY
| $263K | 0.01% |
+81,069
| New | +$351K |
|
|
QADA
686
DELISTED
QAD Inc.
QADA
| $263K | 0.01% |
9,959
-5,450
| -35% | -$139K |
|
|
BNFT
687
DELISTED
Benefitfocus, Inc.
BNFT
| $262K | 0.01% |
5,964
| – | – |
|
|
AMWD
688
DELISTED
American Woodmark
AMWD
| $259K | ﹤0.01% |
4,730
-1,000
| -17% | -$53.2K |
|
|
SCHW
689
Charles Schwab
SCHW
$177B
| $258K | ﹤0.01% |
+7,900
| New | +$250K |
|
|
THOR
690
DELISTED
THORATEC CORPORATION
THOR
| $256K | ﹤0.01% |
+5,740
| New | +$251K |
|
|
SALE
691
DELISTED
RetailMeNot, Inc. Series 1
SALE
| $255K | ﹤0.01% |
+14,317
| New | +$275K |
|
|
LIOX
692
DELISTED
Lionbridge Technologies
LIOX
| $255K | ﹤0.01% |
+41,400
| New | +$242K |
|
|
MDP
693
DELISTED
Meredith Corporation
MDP
| $245K | ﹤0.01% |
4,690
| – | – |
|
|
SF
694
Stifel
SF
$12.3B
| $244K | ﹤0.01% |
+9,517
| New | +$235K |
|
695
Stoneridge
SRI
$209M
| $242K | ﹤0.01% |
20,700
+1,700
| +9% | +$20.5K |
|
696
Foster
FSTR
$443M
| $240K | ﹤0.01% |
6,920
| – | – |
|
|
ACUR
697
DELISTED
Acura Pharmaceuticals
ACUR
| $239K | ﹤0.01% |
48,477
+40,537
| +511% | +$168K |
|
698
Exponent
EXPO
$2.98B
| $238K | ﹤0.01% |
10,640
| – | – |
|
699
Monster Beverage
MNST
$91.4B
| $238K | ﹤0.01% |
10,650
-720,960
| -99% | -$16.1M |
|
|
CBIO
700
Crescent Biopharma
CBIO
$602M
| $236K | ﹤0.01% |
+297
| New | +$246K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2015 Portfolio in Review
As of Q2 2015, Jacobs Levy Equity Management held 928 positions worth $5.26B, down 11% from $5.88B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jacobs Levy Equity Management withdrew a net $615M in Q2 2015, closing 132 positions and reducing 368 holdings. Its most notable exit was BROADCOM CORP CL-A, an estimated $31.3M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Jacobs Levy Equity Management opened a new position in UnitedHealth worth $43.4M.
- Jacobs Levy Equity Management's largest Q2 2015 buy was UnitedHealth: 355,991 shares worth $43.4M.
- Jacobs Levy Equity Management added most to Bristol-Myers Squibb in Q2 2015, an estimated $43.8M increase.
- Jacobs Levy Equity Management's biggest Q2 2015 reduction was Microsoft, cutting an estimated $70.8M.
- Jacobs Levy Equity Management fully exited BROADCOM CORP CL-A in Q2 2015, selling an estimated $31.3M.
- Jacobs Levy Equity Management's ten largest holdings make up 14% of its $5.26B portfolio in Q2 2015.
- Jacobs Levy Equity Management opened 151 new positions and closed 132 in Q2 2015.
- Jacobs Levy Equity Management's portfolio value fell 11% quarter-over-quarter to $5.26B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2015, filed 14 Aug 2015.